Hyep Ivan's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Oct 8, 2025
- Accession no.
- 0002034668-25-000004
- Filed
- Oct 8, 2025
- Trade date
- Oct 6-8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $553.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hyep IvanCIK 0002034668 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | MOption exerciseAcquired | +6,514 | $3.79 | +$24,688.06 | 151,869 | Direct | |
| Oct 6, 2025 | Common Stock | SSaleDisposed | −6,514 | $18.17 | −$118,359.38 | 145,355 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseAcquired | +18,244 | $3.79 | +$69,144.76 | 163,599 | Direct | |
| Oct 7, 2025 | Common Stock | SSaleDisposed | −18,244 | $18.22 | −$332,405.68 | 145,355 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseAcquired | +5,627 | $3.79 | +$21,326.33 | 150,982 | Direct | |
| Oct 8, 2025 | Common Stock | SSaleDisposed | −5,627 | $18.21 | −$102,467.67 | 145,355 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | MOption exerciseDisposed | −6,514 | $0.00 | $0 | 146,870 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseDisposed | −18,244 | $0.00 | $0 | 128,626 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseDisposed | −5,627 | $0.00 | $0 | 122,999 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.